ODAC 30% Off Registration, Use Code: JDD30
Skip to main content
COVID-19 Webinars

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

By May 7, 2020April 22nd, 2021No Comments

JDD Multimedia

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

Join your dermatology colleagues and thought leaders as we examine the hidden impact of COVID-19 on dermatologists and providers, including new and small private practices, emotional wellbeing and the evolving priorities placed on providers during the global coronavirus pandemic. Panelists will discuss their first-hand, personal experience living with COVID-19 and ways it has impacted their physical and emotional health, practice and personal life.
Discussion and guidance will be given on simple steps you can take in the wellness sphere, crisis management and return to practice concepts for both large and small dermatology practices.

Moderators

  • Richard G. Fried, MD, PhD (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)

Panelists

  • Evan Rieder, MD (Board Certified Dermatologist & Psychiatrist, NYU Langone Health)
  • Paul Jarrod Frank, MD (Chief Medical Officer & Founder, PFRANKMD)
  • Melissa Kanchanapoomi Levin, MD (Founder, Entière Dermatology)

You May Also Like

Journal of Drugs in Dermatology JDD featuring Injectable NASHA Gel Skinbooster for Facial Skin Aging in Premenopausal and Postmenopausal Women With Estrogen Deficiency-Associated Not Receiving Hormone Therapy: A Case SeriesAestheticsFeatured ArticlesLatest NewsWomenInjectable NASHA Gel Skinbooster for Facial Skin Aging in Premenopausal and Postmenopausal Women With Estrogen Deficiency-Associated Not Receiving Hormone Therapy: A Case Series
October 26, 2026

Injectable NASHA Gel Skinbooster for Facial Skin Aging in Premenopausal and Postmenopausal Women With Estrogen Deficiency-Associated Not Receiving Hormone Therapy: A Case Series

Addressing Estrogen Deficiency Skin Aging: A Non-Hormonal Approach  Here is an insightful new study featured in the JDD! Intrinsic skin aging associated with estrogen deficiency presents a distinct therapeutic challenge…
Journal of Drugs in Dermatology JDD featuring Off-Label Uses of Nemolizumab: A Narrative ReviewAtopic DermatitisFeatured ArticlesLatest NewsOff-Label Uses of Nemolizumab: A Narrative Review
October 23, 2026

Off-Label Uses of Nemolizumab: A Narrative Review

Beyond AD and PN: Expanding Horizons for Interleukin-31 Blockade in Treatment-Refractory Pruritus  Have you read this article from the JDD? Interleukin-31 receptor alpha targeting has established its place in our…
Journal of Drugs in Dermatology JDD featuring Skincare Mythbusters: The Real Science Behind Benzoyl Peroxide and Sunless TannersEducationFeatured ArticlesLatest NewsMedical DermSkincare Mythbusters: The Real Science Behind Benzoyl Peroxide and Sunless Tanners
October 22, 2026

Skincare Mythbusters: The Real Science Behind Benzoyl Peroxide and Sunless Tanners

Unpacking clinical data on ingredient safety to separate viral fears from evidence-based facts Some of the most read topics in the JDD archive center on ingredient safety, and we want…

Leave a Reply